24,965-share Rule 144 sale notice for Neurocrine (NASDAQ: NBIX)
Rhea-AI Filing Summary
Notification of proposed sale of Common Stock under Rule 144. The filing lists 24,965 shares of Common Stock to be sold on 06/02/2026 described as resulting from an Exercise of Stock Options. The report also lists 9,879 Restricted and Performance Stock Units (02/08/2021) and 2,093 previously exercised stock options (08/04/2020).
The broker is listed as Morgan Stanley Smith Barney LLC and the execution venue is shown as NASDAQ.
Positive
- None.
Negative
- None.
Insights
Form 144 notice lists a sale of 24,965 Common shares tied to option exercise.
The filing records a proposed sale under Rule 144 on 06/02/2026 by a broker-dealer, with the principal method listed as Exercise of Stock Options. The entry also enumerates related equity items: 9,879 RSUs and 2,093 previously exercised options, which appear as provenance for saleable shares.
Timing and cash‑flow treatment are those typical of Rule 144 notices; subsequent Form 4 or sale confirmations will show actual transaction settlement and proceeds.